These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 36700218)

  • 1. Conversion therapy for advanced intrahepatic cholangiocarcinoma with lenvatinib and pembrolizumab combined with gemcitabine plus cisplatin: A case report and literature review.
    Zhang W; Luo C; Zhang ZY; Zhang BX; Chen XP
    Front Immunol; 2022; 13():1079342. PubMed ID: 36700218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micro-lymph node metastasis in intrahepatic cholangiocarcinoma showing pathological complete response to primary tumor and intrahepatic metastasis treated by gemcitabine plus cisplatin chemotherapy and radical surgery.
    Shibata Y; Sudo T; Tazuma S; Tazawa H; Suzuki T; Onoe T; Shimizu Y; Tashiro H; Kuraoka K; Takahashi S
    Clin J Gastroenterol; 2023 Feb; 16(1):81-86. PubMed ID: 36239900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A Case of an Advanced Intrahepatic Cholangiocarcinoma Effectively Treated by Conversion Surgery after Neoadjuvant Chemotherapy of Gemcitabine, Cisplatin and S-1].
    Ogura N; Hoshino M; Hayashi T; Odaira M; Harada H; Hirose S; Funakoshi S
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1665-1667. PubMed ID: 36733169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy analysis of HAIC combined with lenvatinib plus PD1 inhibitor vs. first-line systemic chemotherapy for advanced intrahepatic cholangiocarcinoma.
    Lin Z; Zou X; Hu X; Huang D; Chen Y; Lin J; Li X; Zhang J
    Sci Rep; 2024 Oct; 14(1):23961. PubMed ID: 39397104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case Report: Camrelizumab combined with gemcitabine and oxaliplatin in the treatment of advanced intrahepatic cholangiocarcinoma: a case report and literature review.
    Zhang Z; Wang X; Li H; Sun H; Chen J; Lin H
    Front Immunol; 2023; 14():1230261. PubMed ID: 37671157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A Case of Liver Metastasis of Intrahepatic Cholangiocarcinoma That Achieved Clinical Complete Response after Gemcitabine and Cisplatin Combination Chemotherapy].
    Kim Y; Hata T; Tanizaki K; Okano M; Kawada J; Okuyama M; Yamasaki M; Murakami M; Shimizu J; Miwa H; Imamoto H; Tsujinaka T
    Gan To Kagaku Ryoho; 2019 Feb; 46(2):360-362. PubMed ID: 30914560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical response to adding pyrotinib to pembrolizumab and lenvatinib for HER2-positive advanced intrahepatic cholangiocarcinoma: a case report.
    Zhang JW; Yang X; Pan B; Xu Y; Lu X; Zhao HT
    World J Surg Oncol; 2023 Mar; 21(1):108. PubMed ID: 36973682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Factors for Survival in Patients with Advanced Intrahepatic Cholangiocarcinoma Treated with Gemcitabine plus Cisplatin as First-Line Treatment.
    Ishimoto U; Kondo S; Ohba A; Sasaki M; Sakamoto Y; Morizane C; Ueno H; Okusaka T
    Oncology; 2018; 94(2):72-78. PubMed ID: 29017161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant response to anti-PD-1 based immunotherapy plus lenvatinib for recurrent intrahepatic cholangiocarcinoma with bone metastasis: A case report and literature review.
    Chen WX; Li GX; Hu ZN; Zhu P; Zhang BX; Ding ZY
    Medicine (Baltimore); 2019 Nov; 98(45):e17832. PubMed ID: 31702638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete response of recurrent perihilar cholangiocarcinoma following sintilimab combined with lenvatinib plus S-1: a case report and review of literature.
    Liu QQ; Yu XH; Tang QB; Chen D; Zhang R; Liu C; Shi XD
    Anticancer Drugs; 2024 Jan; 35(1):81-85. PubMed ID: 37227031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of advanced intrahepatic cholangiocarcinoma successfully treated with chemosensitivity test-guided systemic chemotherapy.
    Abe K; Wakatsuki T; Katsushima F; Monoe K; Kanno Y; Takahashi A; Yokokawa J; Ohira H
    World J Gastroenterol; 2009 Nov; 15(41):5228-31. PubMed ID: 19891026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential efficacy of hepatic arterial infusion chemotherapy using gemcitabine, cisplatin, and 5-fluorouracil for intrahepatic cholangiocarcinoma.
    Ishii M; Itano O; Morinaga J; Shirakawa H; Itano S
    PLoS One; 2022; 17(4):e0266707. PubMed ID: 35452492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemcitabine and Cisplatin as Neo-Adjuvant for Cholangiocarcinoma Patients Prior to Liver Transplantation: Case-Series.
    Abdelrahim M; Al-Rawi H; Esmail A; Xu J; Umoru G; Ibnshamsah F; Abudayyeh A; Victor D; Saharia A; McMillan R; Al Najjar E; Bugazia D; Al-Rawi M; Ghobrial RM
    Curr Oncol; 2022 May; 29(5):3585-3594. PubMed ID: 35621680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of stage IIIB intrahepatic cholangiocarcinoma using neoadjuvant therapy with the PD-1 inhibitor camrelizumab: A case report.
    Zhu SG; Li HB; Dai TX; Li H; Wang GY
    World J Clin Cases; 2022 Sep; 10(27):9743-9749. PubMed ID: 36186195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radical Resection Followed by Chemotherapy for Intrahepatic Cholangiocarcinoma with Lymph Node Metastases-Report of a Long-Term Survivor].
    Abe S; Sakata J; Miura K; Saito S; Nagaro H; Miura Y; Ando T; Ishikawa H; Takizawa K; Muneoka Y; Tajima Y; Ichikawa H; Shimada Y; Kobayashi T; Wakai T
    Gan To Kagaku Ryoho; 2023 Feb; 50(2):227-229. PubMed ID: 36807180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of curative resection after downsizing chemotherapy in initially unresectable locally advanced intrahepatic cholangiocarcinoma].
    Aoki Y; Suzuki T; Kato A; Shimizu H; Ohtsuka M; Yoshitomi H; Furukawa K; Takayashiki T; Kuboki S; Takano S; Okamura D; Suzuki D; Sakai N; Kagawa S; Miyazaki M
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1509-11. PubMed ID: 25731235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial.
    Cercek A; Boerner T; Tan BR; Chou JF; Gönen M; Boucher TM; Hauser HF; Do RKG; Lowery MA; Harding JJ; Varghese AM; Reidy-Lagunes D; Saltz L; Schultz N; Kingham TP; D'Angelica MI; DeMatteo RP; Drebin JA; Allen PJ; Balachandran VP; Lim KH; Sanchez-Vega F; Vachharajani N; Majella Doyle MB; Fields RC; Hawkins WG; Strasberg SM; Chapman WC; Diaz LA; Kemeny NE; Jarnagin WR
    JAMA Oncol; 2020 Jan; 6(1):60-67. PubMed ID: 31670750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lenvatinib Plus Programmed Cell Death Protein-1 Inhibitor Beyond First-Line Systemic Therapy in Refractory Advanced Biliary Tract Cancer: A Real-World Retrospective Study in China.
    Shi C; Li Y; Yang C; Qiao L; Tang L; Zheng Y; Chen X; Qian Y; Yang J; Wu D; Xie F
    Front Immunol; 2022; 13():946861. PubMed ID: 35967452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed response to maintenance therapy after first-line chemotherapy in metastatic intrahepatic cholangiocarcinoma: a case report.
    Marciano R; Servetto A; Bianco C; Bianco R
    J Med Case Rep; 2017 Sep; 11(1):273. PubMed ID: 28946921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of unresectable locally advanced intrahepatic cholangiocarcinoma that achieved pathological complete response after gemcitabine and S1 chemotherapy.
    Sumiyoshi T; Uemura K; Shintakuya R; Okada K; Otsuka H; Serikawa M; Ishii Y; Tsuboi T; Arihiro K; Takahashi S
    Clin J Gastroenterol; 2022 Dec; 15(6):1164-1168. PubMed ID: 36181621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.